drugset / Trial / NCT01387607

A Study For Pregabalin In Patients With Fibromyalgia

NCT01387607

Phase 3 Completed 343 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and tolerability of pregabalin compared with placebo for management of fibromyalgia in adults.

Timeline

Start
2012-02-06
Primary completion
2016-10-31
Completion
2016-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 300 mg
Subject Pregabalin Small molecule 450 mg

Indications